Previous Article | Next Article 
Infection and Immunity, January 2001, p. 159-169, Vol. 69, No. 1
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.159-169.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Description of Staphylococcus Serine Protease
(ssp) Operon in Staphylococcus aureus and
Nonpolar Inactivation of sspA-Encoded Serine
Protease
Kelly
Rice,1
Robert
Peralta,1
Darrin
Bast,2
Joyce
de
Azavedo,2 and
Martin J.
McGavin1,*
University of Toronto Department of
Laboratory Medicine and Pathobiology, and Sunnybrook and Womens'
College Health Science Centre, Department of Microbiology, North York,
Ontario, Canada M4N 3M5,1 and Mt. Sinai
Hospital and Toronto Medical Laboratories, University of Toronto,
Toronto, Ontario, Canada M5G 1X52
Received 3 July 2000/Returned for modification 28 August
2000/Accepted 2 October 2000
 |
ABSTRACT |
Signature tagged mutagenesis has recently revealed that the Ssp
serine protease (V8 protease) contributes to in vivo growth and
survival of Staphylococcus aureus in different infection
models, and our previous work indicated that Ssp could play a role in controlling microbial adhesion. In this study, we describe an operon
structure within the ssp locus of S. aureus
RN6390. The ssp gene encoding V8 protease is designated as
sspA, and is followed by sspB, which encodes a
40.6-kDa cysteine protease, and sspC, which encodes a
12.9-kDa protein of unknown function. S. aureus SP6391 is
an isogenic derivative of RN6390, in which specific loss of SspA
function was achieved through a nonpolar allelic replacement mutation.
In addition to losing SspA, the culture supernatant of SP6391 showed a
loss of 22- to 23-kDa proteins and the appearance of a 40-kDa protein
corresponding to SspB. Although the 40-kDa SspB protein could degrade
denatured collagen, our data establish that this is a precursor form
which is normally processed by SspA to form a mature cysteine protease.
Culture supernatant of SP6391 also showed a new 42-kDa glucosaminidase and enhanced glucosaminidase activity in the 29 to 32 kDa range. Although nonpolar inactivation of sspA exerted a
pleiotropic effect, S. aureus SP6391 exhibited enhanced
virulence in a tissue abscess infection model relative to RN6390.
Therefore, we conclude that SspA is required for maturation of SspB and
plays a role in controlling autolytic activity but does not by itself
exert a significant contribution to the development of tissue abscess infections.
 |
INTRODUCTION |
The serine protease of
Staphylococcus aureus strain V8 (Ssp, also known as V8
protease) was one of the first secreted enzymes of S. aureus
to be purified and characterized in detail (16). It is a
member of the glutamyl endopeptidase family of enzymes (24) and has been widely used in this capacity as a
specific tool for determining protein structure. However, its
contributions to the growth and survival of S. aureus have
not been elucidated. S. aureus is a major cause of
infectious morbidity and mortality in both the community and hospital
settings (30), and although capable of expressing several
different toxins, it is not generally equated with other pathogens that
cause illness primarily through the elaboration of specific toxins
(17). Rather, the hallmarks of S. aureus
disease are its rapid multiplication and induction of inflammation at
the site of infection and its ability to disseminate and initiate
metastatic infection (50, 51). This is facilitated by an
accessory gene regulator locus, agr, which at high cell density is responsible for inducing the expression of secreted toxins
and exoenzymes, while simultaneously promoting the reduced expression
of cell surface adhesins and colonization factors (18, 38, 41,
48). Therefore, agr-null mutants demonstrate enhanced expression of colonization factors and a pleiotropic defect in expression of secreted virulence factors.
Due to the inability to express secreted virulence factors,
agr-null strains of S. aureus exhibit attenuated
virulence in several different infection models, and similar
observations apply to a second regulatory locus, sar, which
is required for optimal transcription of agr (5, 12,
14). However, with few exceptions, the function of individual
secreted proteins is less well defined. In this respect, a signature
tagged mutagenesis (STM) study has recently indicated that the Ssp
serine protease contributes to in vivo growth and survival of S. aureus RN6390 in each of three different infection models
(14). Remarkably, although S. aureus secretes
numerous toxins and tissue-degrading enzymes, Ssp was the only secreted
protein identified by STM as being required for the in vivo growth and
survival of S. aureus. Our previous work also implicated a
role for Ssp in degrading a cell surface fibronectin (Fn) binding
protein (32), suggesting that Ssp could play an important
role in controlling the stability and/or processing of cell surface
proteins. These findings collectively indicate a significant
contribution of the Ssp serine protease towards the growth and survival
of S. aureus.
Herein, we present the first application of molecular techniques
towards providing a detailed understanding of the functions of a
secreted protease of S. aureus. Through sequence analysis of
the S. aureus strain COL genome
(http://www.tigr.org), we have found that the
ssp structural gene (sspA) is followed closely by
an open reading frame encoding a cysteine protease, designated sspB. The sspA and sspB proteases are
transcribed as an operon, which also includes a third open reading
frame sspC, of unknown function. Through construction of a
nonpolar allelic replacement mutation, inactivation of sspA
was achieved without affecting transcription of sspB or
sspC. Loss of the SspA serine protease function resulted in
a pleiotropic effect on the profile of secreted proteins, including
autolysin activity and proteolytic maturation of the SspB cysteine
protease, but did not result in attenuated virulence in a tissue
abscess model of infection. Therefore, SspA alone does not exert a
significant contribution to tissue abscess infections. Others have
shown that SspA is itself expressed as an inactive precursor that is
activated by a metalloprotease (15). Therefore, we have
defined a step in a cascade pathway of proteolytic activity, where
metalloprotease is required for maturation of SspA, which then
processes SspB and controls autolytic activity.
Nucleotide sequence accession number.
The nucleotide sequence
of the ssp operon has been deposited in GenBank (accession
number AF309515).
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
Bacterial strains
and recombinant plasmids used in this study are listed in Table
1. S. aureus was cultured at
37°C in brain heart infusion (BHI) broth (Difco, Detroit, Mich.), NZY
broth (20), or medium optimized for protease expression
(16). Escherichia coli DH5
was grown at
37°C in Luria-Bertani medium (Difco). Culture media were supplemented
with agar (15 g·l
1; Difco) where required, and with
ampicillin (50 µg·ml
1), erythromycin (10 µg·ml
1), chloramphenicol (5 µg·ml
1), or tetracycline (5 µg·ml
1)
when needed for selective purposes. For phenotypic assays, a single-colony inoculum was grown overnight in the appropriate medium on
an orbital shaker (250 rpm) and then subcultured into prewarmed medium
in Erlenmeyer flasks to achieve an initial optical density at 600 nm
(OD600) of 0.1. For assays of Fn binding and coagulase
activity, cells were harvested from BHI broth at mid-exponential (2 h)
or stationary phase (6 to 7 h). Cell pellets were processed for
assay of Fn binding (54), while culture supernatants were frozen at
70°C for coagulase assay. For protease and protein profile determinations, cultures were grown in protease culture medium
for 8 or 18 h, and samples of cell culture supernatant were stored
at
70°C. For analysis of autolysin profiles, cultures were grown to
stationary phase in NZY broth (20), and cell culture supernatant was concentrated 30-fold in a Centricon-3
micro-concentrator (Millipore, Bedford, Mass.).
Inactivation of V8 protease (ssp-encoded) structural
gene.
Recombinant plasmids and nucleotide primers for PCR
amplification are listed in Tables 1 and
2, respectively. Construction of the
pVE1C vector for inactivation of sspA was performed in E. coli DH5
, as outlined in Table 1. The ssp
gene (9) was amplified from S. aureus RN4220
with primers sspA-F1 and sspA-R1 and then cloned in pUC18 using a
HindIII site incorporated by the forward primer and an
XbaI site at nucleotide 1383 of the ssp sequence,
near the 3' end of the PCR amplicon. The resulting plasmid is
designated pUC-V8. The ermAB rRNA methylase of
Tn917 (49) was amplified from plasmid pPQ126
(31), with primers Tn917-F and Tn917-R that incorporate
terminal BamHI sequences. The 1.4-kb amplicon was cloned in
pBKS+, creating pBS-E1. The ermAB fragment was excised from
pBSE1, blunt ended with T4 polymerase, and ligated to pUC-V8 at a
unique BsmI site at nucleotide 650 of sspA,
creating plasmid pUC-VE. A fragment of S. aureus plasmid pPQ126 (31) containing the pE194ts temperature-sensitive
plasmid replication origin and chloramphenicol acetyl transferase was excised with PstI and XbaI. After cloning in
pUC18, the fragment was excised from the resulting pUC-VE plasmid with
P
uII and ligated to SmaI-digested pUC-VE,
creating shuttle vector pVE1C.
pVE1C was transformed into S. aureus RN4220 by
electroporation (36), selecting for erythromycin-resistant
(Emr) transformants on BHI agar at 30°C. Mutants
containing pVE1C integrated within the sspA allele were then
selected by growth at 42°C on BHI agar supplemented with erythromycin
(10 µg·ml
1), as described by Greene et al.
(19). One mutant designated SP4221 was used as the donor
strain for transfer of the mutation to S. aureus strain
RN6390 by transduction with phage 85 (36). Emr
transductants were replica plated on BHI containing chloramphenicol (5 µg·ml
1), and an Emr Cms
transductant was designated SP6391. Southern blotting of
HindIII-digested genomic DNA from this strain with
probes specific for sspA and ermAB confirmed the
expected allelic replacement mutation (data not shown).
Sequence analyses.
Nucleotide sequence data used to identify
the ssp operon in S. aureus COL was obtained from
The Institute for Genomic Research (http://www.tigr.org).
Nucleotide sequence analysis was conducted with the IBI MacVector
program (Eastman Kodak, New Haven, Conn.). Homology searches were
conducted using the BLAST algorithms (1, 2) provided by
the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov). Protein sequence analysis was performed using programs provided by the ExPasy Proteomics Tools molecular biology server (3), at http://www.expasy.ch/tools.
PCR conditions.
Primers used for PCRs are described in Table
2. DNA segments were amplified in a volume of 25 µl, containing 1.0 ng of template DNA, 1.5 mM MgCl2, 1.5 µM (each) forward
and reverse primers, 0.2 mM deoxynucleoside triphosphate mix, and 1.25 U of AmpliTaq DNA polymerase (Roche Canada, Laval, Quebec, Canada),
using the buffer as supplied by the manufacturer. Cycling conditions
consisted of a 4-min denaturation at 94°C followed by 30 cycles with
denaturation at 94°C for 1 min, annealing at 52°C for 2 min, and
extension at 72°C for 1 min. Where necessary, PCR products were gel
purified using the GeneClean II kit (Bio 101; Vista, Calif.) for use in cloning experiments, or as probes in Southern and Northern blots.
Southern and Northern blotting.
DNA probes for Southern
blots were generated by PCR as described above, using primers
sspA-F1-sspA-R1 and Tn917-F-Tn917-R (Table 2). Additional probes for
Northern blots were generated by PCR using primers sspB-F1-sspB-R1,
sspC-F1-sspC-R1, sspA-F3-sspA-R2, and RNAIII-F-RNAIII-R. All probes
were labeled with the ECL direct nucleic acid labeling system
(Amersham-Pharmacia, Piscataway, N.J.). S. aureus genomic
DNA was purified using QIAGEN 100/G genomic tips (Qiagen, Inc.,
Valencia, Calif.), following the manufacturer's protocol for
gram-positive bacteria. RNA was prepared from stationary-phase (8 h)
S. aureus cultures grown in protease culture medium, using TRIZOL reagent (Gibco/BRL, Gaithersburg, Md.) and the
FASTPREP FP120 instrument (Bio 101) as described previously
(40). The concentration and purity of each sample were
determined by measuring the absorbance at 260 and 280 nm.
For Southern blotting, 1.0 µg of HindIII-digested
genomic DNA was electrophoresed through 0.8% (wt·vol
1)
agarose containing ethidium bromide (0.5 µg·ml
1), in
Tris-acetate-EDTA buffer. DNA was blotted by capillary transfer to
Hybond N+ membrane (Amersham) using the alkaline transfer method (29). Northern blot analysis was performed with 10 µg of
RNA after electrophoresis in 1.0% (wt·vol
1) agarose
containing 0.66 M formaldehyde in morpholine propanesulfonic (MOPS)
acid running buffer (20 mM MOPS, 10 mM sodium acetate, 2 mM EDTA [pH
7.0]). For estimation of transcript sizes, 10 µg of RNA molecular
weight standards (Sigma) ranging in size from 0.2 to 10 kb were
electrophoresed next to RNA from S. aureus RN6390. RNA was
transferred to a Hybond N+ membrane in 10× SSC buffer (0.15 M
Na3-citrate, 1.5 M NaCl [pH 7.0]), and fixed to the
membrane by baking at 80°C for 2 h. Processing of the blotted
membranes was performed using the reagents and protocols provided with
the ECL direct nucleic acid labeling and detection system
(Amersham-Pharmacia), using Kodak Biomax ML autoradiography film.
SDS-PAGE, zymography, Western blotting, and N-terminal
sequencing.
To determine profiles of secreted proteins, cell
culture supernatant was mixed with an equal volume of ice cold 20%
(wt·vol
1) trichloroacetic acid (TCA) and incubated on
ice for 60 min. After centrifugation, (12,000 × g; 10 min) precipitated proteins were washed in ice-cold 70%
(vol·vol
1) ethanol, air dried, and solubilized in 1×
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
reducing buffer. The samples were then subjected to SDS-PAGE as
described by Laemmli (27). Proteins were visualized by
staining with Coomassie blue. For zymography, culture supernatants were
subjected to SDS-PAGE using 12% (wt·vol
1) acrylamide
Zymogram Ready Gels (Bio-Rad, Hercules, Calif.) containing casein or
gelatin (1 mg·ml
1). Following electrophoresis, the gels
were shaken gently for 60 min at room temperature, in
phosphate-buffered saline (PBS) containing 2.5%
(vol·vol
1) Triton X-100 (Sigma). The gels were then
incubated overnight at 37°C in buffer containing 50 mM Tris-HCl (pH
7.4), 200 mM NaCl, 5 mM CaCl2, 0.02%
(vol·vol
1) Triton X-100, and 1 mM cysteine. The gels
were then stained with Coomassie blue dye and destained to reveal zones
of protease activity. Where indicated, culture supernatants were
preincubated with specific protease inhibitors (DFP, 10 mM; E-64, 10 µM), and the same inhibitors were included in the development buffer.
Zymograms for detection of autolysin activity were conducted as
described previously (45), using acrylamide gels
containing heat-killed and lyophilized Micrococcus luteus
(Sigma) or S. aureus RN6390 cells (1 mg·ml
1). Zones of autolytic activity were detected by
counterstaining with methylene blue. Sample volumes were adjusted to
represent equivalent optical density at 600 nm (OD600)
units, based on the cell density of each stationary-phase culture.
V8 protease in culture supernatants was detected by Western
immunoblotting. To generate specific antibodies, each of two female New
Zealand White rabbits were immunized by subcutaneous injection with 100 µg of purified V8 protease from S. aureus L530
(32), mixed with Freund's complete adjuvant (Sigma).
Booster injections were administered at 2-week intervals, consisting of
100 µg of V8 protease mixed with 0.5 ml of Freund's incomplete
adjuvant (Sigma). Purified V8 protease was employed for blot
purification of monospecific antibodies, using pooled antisera from the
second and third booster injections. For Western immunoblots, proteins from stationary-phase culture supernatants were subjected to SDS-PAGE through 12% (wt·vol
1) polyacrylamide gels, and
transferred to Immobilon-P membranes (55). Western
blotting was performed with blot-purified anti-V8 protease antibody as
primary antibody, and alkaline phosphatase-conjugated goat anti-rabbit
(heavy and light chain) immunoglobin G (Jackson Immuno Research, West
Grove, Pa.) (5,000× dilution) as the secondary antibody. Blots were
developed with 5-bromo-4-chloro-3-indolylphosphate and nitroblue
tetrazolium alkaline phosphatase substrates (Bio-Rad).
For N-terminal sequence determination, culture supernatant proteins
were precipitated with TCA and subjected to SDS-PAGE as described
above, followed by transfer to polyvinylidene difluoride membrane in
CAPS buffer, as described previously (57). After light
staining, protein bands were excised with a scalpel and submitted to
the University of Toronto HSC Biotechnology Center for N-terminal sequencing.
Assay of Fn binding, protease, and coagulase activity.
Assays for binding of 125I-Fn were conducted as described
(40), using 5 × 107 S. aureus
cells in each binding assay, with 4.5 × 108
non-Fn-binding S. simulans cells as carriers to assist in
centrifugation. Labeling of Fn with 125I (NEN-Dupont,
Boston, Mass.) was performed using the chloramine-T protocol
(25), to a specific activity of approximately 27 MBq·nmol
1. All assays were performed in duplicate
within 24 h of the labeling reaction. Binding data are expressed
as the percentage of added Fn (50,000 cpm) that was bound by 5 × 107 S. aureus cells. For quantification of
protease activity, samples of 18-h culture supernatants were assayed
with resorufin-labeled casein (Roche) as previously described
(40). The resorufin chromophore solubilized by protease
activity was quantified (A574) after
precipitation of undigested casein with TCA. Coagulase activity in
culture supernatants from exponential (2 h)- or stationary (7 h)-phase
cultures of S. aureus grown in BHI was quantified with
sterile reconstituted rabbit plasma (BBL, Bedford, Mass.) in 10- by
75-mm glass culture tubes as described previously (40).
The coagulase titer was defined as the log2 reciprocal of
the highest dilution producing a firm clot. Protease and coagulase
assays were both performed in duplicate.
Murine tissue abscess model.
Virulence of S. aureus RN6390 and isogenic derivatives was assessed using a murine
tissue abscess model following established protocols (7,
8). Briefly, cells from logarithmic-phase cultures grown in BHI
broth were diluted in sterile PBS and mixed with an equivalent volume
of sterilized Cytodex beads (Sigma) suspended in PBS at a concentration
of 20 µg·ml
1. The suspension (200 µl) was injected
subcutaneously into the right flank of each of eight 4-week-old
hairless crl:SKH1(hrhr)Br mice (Charles River, Wilmington, Mass.),
using a 1-ml tuberculin syringe. The length and width of the lesions
were measured daily, and the wound area (A) was determined
by the formula A =
(L × W)/2, where L is
the longest axis and W is the shortest axis. The mice were
sacrificed at 72 h postchallenge.
Statistical analyses.
Data from phenotypic assays and the
murine tissue abscess model were subjected to statistical analyses, by
both the single-factor analysis of variance and the Bonferroni
t test using the SigmaStat software program (Jandel
Scientific). P values less than or equal to 0.05 were
considered to indicate significant differences.
 |
RESULTS |
Analysis of nucleotide sequence downstream of the
ssp-encoded serine protease in the genome of S. aureus COL.
A BLAST search (2 May 2000 release) of the
S. aureus COL genome identified the ssp serine
protease gene on contiguous nucleotide sequence no. 6218. Analysis of
the nucleotide sequence downstream of ssp revealed two
additional open reading frames (Fig.
1). The serine protease gene designated sspA is followed by
sspB, which encodes a hypothetical protein of 393 amino
acids. The SignalP program (3) predicts a signal peptide
cleavage site after Ala36, creating a mature protein of
40.6 kDa. Amino acids 220 to 393 of SspB possess 47% identity and 64%
similarity to staphopain (Fig. 1B), a 23-kDa cysteine protease purified
from S. aureus strain V8 (23). The PROSCAN
program (3, 4) identified a eukaryotic thiol protease
histidine active site consensus pattern (LGHALAVVGNA), spanning amino
acids 338 to 348, which is also conserved in staphopain (Fig. 1). Just
37 nucleotides from the stop codon of sspB is a third open
reading frame, sspC, which encodes a 109-amino-acid protein
with a predicted size of 12.9 kDa. A cytoplasmic localization was
predicted for SspC using the Psort program (33), and SspC
did not possess significant homology to other known proteins, including
complete and incomplete microbial genomes. Following sspC is
a hairpin structure, representing a possible transcription termination
signal. PCR of genomic DNA with primer pairs sspA-F2-sspB-R2 and
sspB-F2-sspC-R2 (Table 2) confirmed that the same order of genes was
present on the genome of S. aureus RN6390 (data not shown).

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 1.
Nucleotide and deduced amino acid sequence of the
sspB and sspC genes from S. aureus
strain COL (A) and alignment of the C-terminal region of SspB with the
staphopain cysteine protease (23) purified from S. aureus strain V8 (B). (A) The sspA open reading frame
encoding V8 protease terminates at nucleotide 1364, and the nucleotide
coordinates of the ssp operon are additive to the original
ssp sequence of S. aureus strain V8
(9). The 3' end of the published ssp sequence
terminates at nucleotide 1634 of the ssp operon, indicated
by a bullet. Stop codons are indicated by asterisks. The predicted
signal peptide cleavage site in the SspB amino acid sequence is
indicated by a downward-pointing arrow, and the experimentally
determined N-terminal sequence obtained from the 41-kDa SspB protein
secreted by S. aureus SP6391 is represented by a solid
underbar. The dashed underbar represents the N-terminal sequence of a
22-kDa protein secreted in increased abundance in a sarA
mutant of S. aureus 8325-4 (10). An
upward-pointing arrow indicates a potential processing site for
cleavage of SspB at Glu219 by SspA to form a mature
cysteine protease. The double underbar following the sspC
open reading frame indicates a hairpin structure, representing a
putative transcriptional termination signal. (B) The arrow points to an
active site cysteine residue in staphopain, which has been determined
by crystallography to bind the cysteine protease inhibitor, E-64
(23). The boxed and shaded residues in both panels
represent a pattern of amino acids that is identified as a eukaryotic
thiol protease histidine active site. Identical amino acids are
indicated by colons, and lowercase letters represent nonidentical amino
acids.
|
|
Northern blot analysis of the ssp transcript in
S. aureus RN6390 and isogenic mutants.
The
organization of the sspA, sspB, and
sspC genes shown in Fig. 1 is suggestive of an operon
structure. Consequently, it was necessary to inactivate sspA
in S. aureus RN6390 using a nonpolar allelic replacement
strategy. Northern blot analysis provided proof that the ssp
genes are transcribed as an operon and that inactivation of
sspA was achieved without affecting transcription of
downstream genes (Fig. 2). RNA from
S. aureus RN6390 displayed a 2.8-kb transcript that
hybridized with probes specific for sspA, sspB,
or sspC (Fig. 2A to C, lane 1). This is in agreement with the translation start codon of sspA and the stop codon of
sspC being separated by 2.64 kb. Although sspA
was disrupted by insertion of ermAB in SP6391, probes
specific for sspA, sspB, or sspC each detected two RNA transcripts of 4.0 and 4.7 kb (Fig. 2A to C, lane 2).
The same pattern was also observed with a probe specific for
ermAB (data not shown). These findings suggest that
transcription initiated from both the native sspA promoter
and the ermAB cassette continues through the ssp
operon.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 2.
Northern blots of RNA (10 µg) extracted from S. aureus RN6390 (lane 1), SP6391
(sspA::ermAB [lane 2]), SP6912
(agr sspA::ermAB [lane 3]), and
RN6911 (agr [lane 4]). The probes used correspond to
sspA (A), sspB (B), sspC (C), the 5'
end of sspA prior to the ermAB insertion point
(D), or RNAIII (E).
|
|
This was confirmed by transducing the inactivated sspA
allele (sspA::ermAB) of SP6391 into the
agr-null strain S. aureus RN6911, creating strain
SP6912 (agr
::tetM
sspA::ermAB). In this situation, strain
SP6912 displayed a single 4.0-kb ssp transcript (Fig. 2A to
C, lane 3), whereas no ssp transcript was detected in the
agr-null parent strain RN6911 (Fig. 2A to C, lane 4). Both
strains maintained the same defect in transcription of RNAIII (Fig. 2E,
lanes 3 and 4), due to the deletion of the agr locus in
S. aureus RN6911. Therefore, the 4.0-kb ssp
transcript in SP6912 and SP6391 originates from the ermAB
cassette, which permits transcription of sspB and sspC independently of agr function. To confirm
that the larger 4.7-kb ssp transcript in SP6391 originates
from the native sspA promoter, a Northern blot was performed
with a probe obtained by PCR with primer pair sspA-F3 and sspA-R2
(Table 2), spanning the 5' end of sspA prior to the
ermAB insertion point. As expected, this probe hybridized
only to the 4.7-kb transcript of SP6391 and did not detect any
transcript in SP6912. These data demonstrate that sspABC is
transcribed as an operon and that nonpolar inactivation of
sspA has been achieved in strain SP6391.
Inactivation of sspA exerts a pleiotropic effect on the
profile of secreted proteins and proteases.
SDS-PAGE analysis was
performed to assess the affect of the sspA mutation on the
profile of secreted proteins (Fig. 3A).
Culture supernatant of S. aureus SP6391
(sspA::ermAB) possessed a new 40-kDa
protein that was not observed in RN6390. Relative to RN6390, culture
supernatant of SP6391 also exhibited increased abundance of a protein
doublet at approximately 43 kDa, decreased abundance of proteins at 37 and 27 kDa, and loss of at least two minor protein bands at 22 to 23 kDa (lane 2). The new 40-kDa protein in SP6391 corresponds to the
expected size of SspB after processing at a predicted signal peptidase
cleavage site, and N-terminal sequencing of this protein yielded the
sequence DSHSKQLEINV, which matches perfectly with the predicted N
terminus of secreted SspB (Fig. 1A). A protein of the same size was
also present in the culture supernatant of SP6912
(agr
::tetM sspA::ermAB)
(lane 3) and had the same N-terminal sequence DSHSKQLEIN, confirming
its identity as SspB. This protein was not expressed in the
agr-null parent strain RN6911. Therefore, inactivation of
sspA results in accumulation of the 40-kDa SspB protein in
the culture supernatant of SP6391, and transduction of the mutant
allele into the agr-null strain S. aureus RN6911
permits this protein to be expressed and secreted independently of
agr function.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
SDS-PAGE (A) and Western immunoblot (B) of secreted
proteins from S. aureus RN6390 and isogenic derivatives. The
molecular masses of protein standards are indicated to the left of each
gel. (A) Lane 1, S. aureus RN6390; lane 2, SP6391; lane 3, SP6912; lane 4, RN6911. The amount of protein loaded represents the
equivalent of 2.3 OD600 units (lanes 1 and 2) or 6.8 OD600 units (lanes 3 and 4) of original culture. Secreted
proteins are visualized by staining with Coomassie blue dye. (B)
Purified V8 protease (60 ng) from S. aureus L530 (lane 1) or
supernatant corresponding to 0.03 OD600 units of stationary
phase culture from S. aureus RN6390 (lane 2), SP6391 (lane
3), SP6912 (lane 4), or RN6911 (lane 5) was subjected to SDS-PAGE (10%
[wt·vol 1] polyacrylamide), transferred to Immobilon-P
membrane, and probed with blot-purified polyclonal anti-V8 protease
antibody.
|
|
The loss of SspA expression was confirmed by a Western immunoblot,
using antibodies specific for SspA (Fig. 3B). Purified SspA from
S. aureus L530 (lane 1) migrated slightly faster than an
immunoreactive protein of S. aureus RN6390 (lane 2), which was not present in culture supernatant of SP6391 (lane 2). Therefore, the SspA serine protease of S. aureus RN6390 is slightly
larger than that of S. aureus strain L530 and is not
expressed in S. aureus SP6391.
The doublet of proteins at 43 kDa in S. aureus RN6390
(Fig. 3A, lane 1) yielded N-terminal sequences of LKANQVQPLNKYP
and AT(Y?)KAKDDQTRA(V?)V. The former matches perfectly with amino acids 294 to 306 of the S. aureus glycerol ester
hydrolase precursor (28). Signal from the latter sequence
was weaker but resembled amino acids 281 to 289 (ta-KAKDDQT) of a
triacylglycerol hydrolase from S. aureus (35).
Proteins in the same 43-kDa size range were more abundant in the
culture supernatant of S. aureus SP6391 (Fig. 3A, lane 2).
Lipases of S. aureus are secreted as larger precursor forms
of approximately 82 kDa that undergo proteolytic maturation to form
mature proteins of 40 to 45 kDa (46). As loss of SspA
function did not result in the appearance of unprocessed lipase, it
appears that SspA is not required for the proteolytic maturation of
secreted lipases. However, the increased abundance in culture
supernatant from SP6391 of proteins corresponding in size to the mature
lipase enzymes suggests that SspA may influence the stability of
secreted lipase.
Protease zymogram analyses of S. aureus RN6390 and
isogenic derivatives.
Zymogram analyses were conducted to examine
the effect of sspA inactivation on the profile of secreted
proteases. In zymogram gels containing casein, S. aureus
RN6390 exhibited a doublet of closely migrating proteases (Fig. 4A,
lane 2). The more active and slower-migrating protease was absent from
culture supernatant of S. aureus SP6391 (lane 3), and as in
the Western immunoblot, the serine protease of S. aureus
RN6390 was slightly larger than purified SspA from S. aureus
L530 (lane 1). Although the 40-kDa SspB protein was present only in the
culture supernatant of SP6391 and SP6912 (Fig. 3A), no new zones of
protease activity were detected on casein zymograms (Fig. 4A, lanes 3 and 4). However, in zymograms containing
gelatin (Fig. 4B), SP6391 and SP6912 each exhibited a higher mass
protease activity (lanes 3 and 4) that was not present in either RN6390
or RN6911 (lanes 2 and 5). Furthermore, a low-molecular-mass gelatinase
of RN6390 was absent from culture supernatant of SP6391. When the
samples were pretreated with E-64, a specific inhibitor of cysteine
protease activity, the lower-mass gelatinase of RN6390 and the
higher-mass activity in SP6391 and RN6912 were no longer detected (data
not shown). Therefore, inactivation of sspA has resulted in
the loss of a low-molecular-mass cysteine protease and the appearance
of a higher-molecular-mass protease, representing the 40-kDa SspB
protein.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 4.
Zymogram detection of secreted protease activity after
electrophoresis in 12% acrylamide gels containing casein (A) or
gelatin (B) as substrate. (A) For the casein zymogram, sample loading
consisted of purified SspA (200 ng) from S. aureus L530
(lane 1) or supernatant from stationary-phase cultures of S. aureus RN6390 (lane 2), SP6391 (lane 3), SP6912 (lane 4), or
RN6911 (lane 5). The amount of supernatant applied was equivalent to
0.012 OD600 units of stationary-phase culture for lane 2 (RN6390) or 0.03 OD600 units in lanes 3, 4, and 5. (B) The
loading order is the same as that in panel A, except that lane 1 contained 600 ng of purified SspA and lanes 2 to 5 each contained 0.03 OD600 units of stationary phase culture supernatant.
Protease activity appears as a clear zone against a Coomassie
blue-stained background.
|
|
These observations suggest that the SspA serine protease is required
for proteolytic maturation of the 40-kDa form of SspB. Accordingly,
when culture supernatant from SP6912 (agr
sspA::ermAB) was treated with purified SspA
prior to zymogram analysis, the precursor form of SspB was processed to
form lower-molecular-mass gelatinase activities (Fig.
5). Furthermore, as evident from Fig. 3A,
inactivation of sspA resulted in loss of two proteins of 22 to 23 kDa, and appearance of the 40-kDa SspB protein in culture supernatant of SP6391. These observations were also reflected in the
profile of secreted gelatinase activities (Fig. 4B). Cumulatively, these data indicate that SspB is expressed as a 40-kDa precursor protein, which is processed by SspA to form a mature cysteine protease
of 22 to 23 kDa.

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 5.
Zymogram analysis demonstrating conversion of SspB into
lower-molecular-mass forms by treatment with purified SspA. The assay
was performed as described above for Fig. 4B. Lane 1, 150 ng of V8
protease in PBS containing 1 mM cysteine; lane 2, 150 ng V8 protease
pretreated with 10 mM DFP serine protease inhibitor; lane 3, 0.025 OD600 units of stationary-phase culture supernatant from
SP6912; lane 4, supernatant from 0.08 OD600 units of SP6912
culture, incubated for 60 min in PBS containing 300 ng of purified V8
protease and 1 mM cysteine, followed by addition of 10 mM DFP; lane 5, identical to lane 4, except that DFP treatment was omitted. The
higher-molecular-mass activity in lanes 1 and 2 containing purified
SspA represents a shift in mobility that is observed when the sample is
incubated in a reducing agent prior to electrophoresis. Coomassie blue
staining of SDS-PAGE gels containing reduced or nonreduced SspA has
confirmed that SspA exhibits faster migration when nonreduced (data not
shown).
|
|
Inactivation of sspA results in an altered profile of
secreted autolysins.
Through sequence analysis of the partially
complete S. aureus COL genome (http://www.tigr.org), we have
discovered that the atl gene encoding a major autolysin
activity of S. aureus is located 5 kb upstream of the
ssp operon. Atl is expressed as a 138-kDa precursor protein
that is processed by proteolytic activity to release glucosaminidase
(GL) and amidase (AM) domains of 54 and 63 kDa, respectively
(39). To determine if autolytic activity is influenced by
the sspA mutation, zymogram analyses of culture supernatants
were conducted using gels containing M. luteus or S. aureus cells, to detect GL (Fig. 6A)
and AM (Fig. 6B) activity, respectively. Compared to RN6390 (Fig. 6A,
lane 1), S. aureus SP6391 (lane 2) and RN6911 (lane 4) both
exhibited enhanced GL activity in the 30-kDa size range, together with
the appearance of an active 43-kDa GL and a less active 56-kDa GL,
which were not present in RN6390 (Fig. 6A). Therefore, loss of SspA
function has altered the profile of secreted GL activities, resembling that of the agr-null strain, RN6911. In addition, RN6911
exhibited at least three GL activities in the high-molecular-mass range (~97 kDa) that were not evident in either SP6391 or RN6390.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 6.
Detection of secreted GL (A) and AM (B) activity by
electrophoresis of culture supernatants in 10% acrylamide gels
containing heat-killed M. luteus (A) or S. aureus
RN6390 (B) cells (1 mg·ml 1). Lane 1, S. aureus RN6390; lane 2, SP6391; lane 3, SP6912; lane 4, RN6911.
Sample loading was equivalent to either 0.58 OD600 units
(A) or 3.0 OD600 units (B) of stationary-phase culture
supernatant. Autolytic activity appears as a clear zone against a
methylene blue-stained background. The molecular masses of protein
standards are indicated to the left of each gel.
|
|
Although S. aureus SP6391 exhibited a number of weak AM
activities ranging in size from 29- to 56-kDa that were not evident in
RN6390 (Fig. 6B), loss of SspA function did not have the same impact on
AM profiles as it did on GL activity. When the autolysin profiles of
RN6911 (agr) and SP6912 (agr
sspA::ermAB) were compared, RN6911 exhibited
a 105-kDa autolysin that was active on both GL and AM substrates and
also a faint 73-kDa AM activity that were not detected in SP6912. As
these two strains differ only in the sspA::ermAB mutation that results in
secretion of the SspB cysteine protease, this result suggests that SspB
may process the high-molecular-mass precursor forms of specific autolysins.
Quantitative assessment of virulence and virulence factor
expression.
Total protease activity in culture supernatant of
S. aureus SP6391 was diminished by more than 60% relative
to RN6390, as determined with resorufin-labeled casein (Table
3). Culture supernatant of S. aureus RN6911 was devoid of protease activity, consistent with the
deletion of the agr locus in this strain. Although the protease activity of SP6912 was numerically 10-fold greater than that
of RN6911 (0.039 versus 0.004), it was still very low. Therefore, as
also evident from zymogram analysis, this protease is active on gelatin
but does not exhibit appreciable activity towards casein. S. aureus strains RN6390 and SP6391 both showed growth
phase-dependent reduction in coagulase titer and Fn binding and did not
differ significantly from one another in either of these activities. Therefore, inactivation of sspA function did not affect the
stability of these proteins. Results from Fn binding and coagulase
assays of RN6911 were as expected for the agr-null mutant
phenotype of this strain.
When the virulence of RN6390 and that of SP6391 were assessed using a
murine abscess infection model, mice challenged with SP6391 exhibited a
larger area of tissue abscess at each of 24, 48, and 72 h
postchallenge compared to S. aureus RN6390 (Table 4). This difference was statistically
significant at 72 h but not at 24 or 48 h. Although the mice
challenged with SP6391 received a larger challenge inoculum, these data
were also reproducible at smaller challenge doses. Therefore, loss of
serine protease function has not impaired the ability of SP6391 to form
a tissue abscess.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Surface area of tissue abscess at indicated time points
following challenge with S. aureus RN6390 and
isogenic derivatives
|
|
 |
DISCUSSION |
We have identified an operon structure encoding the secreted
serine and cysteine proteases SspA and SspB of S. aureus.
The organization of the operon and our experimental findings indicate a
sequential pathway in which the SspA serine protease is required for
proteolytic maturation of SspB. This conclusion is supported by a study
on the phenotype of a sarA mutation in S. aureus.
Although the SarA protein is required for optimal transcription of the agr locus (11, 13), it also represses
expression of secreted proteases. Inactivation of sarA in
S. aureus 8325-4 resulted in the appearance in the culture
supernatant with elevated levels of V8 protease (SspA), a putative
metalloprotease, and a 22-kDa protein designated P4 (10).
The reported N-terminal sequence of P4 matches perfectly with amino
acids 231 to 250 of SspB (Fig. 1A), suggesting that the 22-kDa P4
protein originated from processing of the 40-kDa precursor form of SspB
after Glu219. This is consistent with the SspA serine
protease's exhibiting a high specificity for cleavage on the
carboxyl-side of glutamic acid residues (24). These
observations, combined with the results from our present study, define
a requirement for the SspA serine protease in proteolytic maturation of
the 40-kDa SspB cysteine protease. To our knowledge, this is the first
report of an operon structure containing two tandem protease genes, in
which the activity of the first encoded protease is required to process
the second.
Others have shown that the V8 protease (SspA) is secreted as an
inactive precursor form, which is processed by the metalloprotease aureolysin to form the mature serine protease (15).
Aureolysin is also expressed as a precursor form (47), but
its mechanism of maturation is not known. Therefore, there is a cascade
pathway in the maturation of the secreted proteases of S. aureus, where the aureolysin metalloprotease activates the SspA
serine protease, which in turn is required for proteolytic maturation
of the SspB cysteine protease. It is not known if similar pathways
exist in other gram-positive pathogens, but there is an interesting
parallel with the cotranscribed gelE gelatinase and
sprE serine protease of Enterococcus faecalis
(44). A BLAST search reveals that gelE and
sprE exhibit the greatest homology towards the aureolysin and SspA proteases respectively of S. aureus. Therefore, the
gelE-sprE transcriptional unit of E. faecalis may
represent another example of an operon structure in which the first
encoded protease serves to process the second.
A gene encoding an N-acetylmuramidase activity is upstream
of the gelE-sprE operon of E. faecalis
(44), and searching of the S. aureus COL genome
reveals that the major atl autolysin of S. aureus
is also upstream of the ssp operon. Oshida et al. have shown
that processing of the high-molecular-mass form of Atl can be blocked
with protease inhibitors (39). However, loss of SspA
function did not result in the appearance of an autolysin corresponding
in size to the 138-kDa precursor form of Atl. Therefore, it appears
that SspA is not required for maturation of the Atl autolysin. Our
finding that loss of SspA resulted in enhanced levels of a 29- to
32-kDa GL and appearance of a 43-kDa GL suggests that SspA functions to
control autolytic activity. This is consistent with a report in which
protease-hyperproducing strains of Bacillus subtilis
exhibited decreased rates of peptidoglycan turnover, while cultures
supplemented with a serine protease inhibitor demonstrated an increased
rate of cell wall turnover (26). However, it is not clear
from our data if SspA serves to inactivate autolytic function or if the
43-kDa GL appearing in the culture supernatant of SP6391 is due to
another mechanism. In this respect, inactivation of the
lrgAB operon in S. aureus RN6390 resulted in the
appearance of 43 to 56-kDa autolytic activities (20). It
was proposed that the LrgAB proteins act as antiholins, thereby
prohibiting the export of autolysins. Therefore, proteases could
influence autolytic activity at multiple levels, including inactivation
of autolytic activity, or by controlling the stability of holin and
antiholin proteins that moderate autolysin secretion.
Enhanced autolytic activity may have contributed to the slight increase
in virulence of S. aureus SP6391 in the tissue abscess infection model, perhaps by promoting the release of proinflammatory cell wall material. This result differs from a finding in which STM was
applied towards S. aureus RN6390. In this study, a
Tn917 insertion in the ssp-encoded serine
protease resulted in moderate attenuation of virulence in tissue
abscess and burn wound infection models and strong attenuation in a
systemic infection model (14). Possibly, the
ssp mutant obtained by STM exerted a polar effect on
transcription of genes downstream of sspA. Therefore, the
attenuated virulence attributed to SspA may have been due to the loss
of function conferred by sspB and sspC. Similar
considerations affected the determination of phenotype attributed the
gelE gelatinase of E. faecalis. Initially,
inactivation of gelE was reported to result in a
significantly delayed time to death in a peritonitis model of infection
(53). However, a subsequent study revealed that
inactivation of gelE exerted a polar effect on the
cotranscribed sprE serine protease (44).
Therefore, the virulence phenotype could not be attributed to
gelE alone.
Except for its homology to the staphopain cysteine protease purified
from S. aureus strain V8 as noted in Fig. 1, SspB exhibits no significant homology towards any other protein. The 40-kDa precursor
form of SspB is active on gelatin, suggesting that proteolytic processing is not an absolute requirement for activity. This differs from the 40-kDa SpeB cysteine protease of Streptococcus
pyogenes, which is secreted as an inactive zymogen that undergoes
autocatalytic conversion to form a mature cysteine protease
(21). In contrast, the periodontain and gingipain cysteine
proteases of Porphyromonas gingivalis are expressed as
active precursors that undergo proteolytic maturation (42,
43). As with SspB, periodontain was active on gelatin zymograms
but exhibited no activity towards casein. Periodontain also exhibited
no activity towards a number of other structured proteins
(34), with the exception of its ability to cleave and
inactivate plasma
1-proteinase inhibitor
(
1-PI). The
1-PI normally functions to
limit tissue destruction during inflammatory responses by moderating
the activity of the large quantities of human neutrophil elastase and
cathepsin G released by degranulating neutrophiles. Consequently,
inactivation of
1-PI by periodontain was proposed to
promote the destructive inflammation associated with acute P. gingivalis gingivitis. Others have reported that V8 protease
(SspA) of S. aureus can cleave
1-PI and that the cleaved product was a potent chemoattractant of human neutrophiles (6). However, our data did not support a role for SspA in
promoting the inflammation associated with tissue abscess formation.
The SspA-defective mutant also did not exhibit enhanced Fn binding, as
predicted from our previous work in which purified V8 protease promoted
the rapid loss of cell-surface fibronectin binding protein when added
to early-exponential-phase cultures of S. aureus clinical
isolates (32). Possibly, growth phase-dependent loss of
cell surface Fn-binding protein may represent the combined effect of
two or more proteases. In this respect, we have shown that loss of SspA
function promoted a pleiotropic phenotype, including failure to process
the secreted precursor form of SspB, and appearance of new autolytic
activities in the culture supernatant. Therefore, the secreted
proteases of S. aureus may cumulatively exert a profound effect on the growth and physiology of this diverse microbial pathogen.
Studies are in progress to precisely define the functions of the SspB
cysteine protease and SspC, which is predicted to reside in the
cytoplasm and exhibits no significant homology to any other known protein.
 |
ACKNOWLEDGMENTS |
This work was funded by Medical Research Council operating grant
MOP-12669. K.R. is the recipient of an Ontario Graduate Scholarship award.
We thank Christine Watt for technical assistance. Sequencing of the
S. aureus COL genome was accomplished with support from the
National Institutes of Allergy and Infectious Diseases and the Merck
Genome Research Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: S-112 Department
of Microbiology, Sunnybrook and Women's College Health Science Centre, North York, Ontario, Canada M4N 3M5. Phone: (416) 480-5831. Fax: (416)
480-5737. E-mail: martin.mcgavin{at}swchsc.on.ca.
Editor:
E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 3.
|
Appel, R. D.,
A. Bairoch, and D. F. Hochstrasser.
1994.
A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server.
Trends Biochem. Sci.
19:258-260[CrossRef][Medline].
|
| 4.
|
Bairoch, A.,
P. Bucher, and K. Hofmann.
1997.
The PROSITE database, its status in 1997.
Nucleic Acids Res.
25:217-221[Abstract/Free Full Text].
|
| 5.
|
Balaban, N.,
T. Goldkorn,
R. T. Nhan,
L. B. Dang,
S. Scott,
R. M. Ridgley,
A. Rasooly,
S. C. Wright,
J. W. Larrick,
R. Rasooly, and J. R. Carlson.
1998.
Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.
Science
280:438-440[Abstract/Free Full Text].
|
| 6.
|
Baran, K.,
M. Gorka,
J. Potempa, and Z. Porwit-Bobr.
1989.
Chemoattractant activity of Staphylococcus aureus serine proteinase modified human plasma alpha-1-proteinase inhibitor.
Antonie Leeuwenhoek
56:361-365.
|
| 7.
|
Betschel, S. D.,
S. M. Borgia,
N. L. Barg,
D. E. Low, and J. C. de Azavedo.
1998.
Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S.
Infect. Immun.
66:1671-1679[Abstract/Free Full Text].
|
| 8.
|
Bunce, C.,
L. Wheeler,
G. Reed,
J. Musser, and N. Barg.
1992.
Murine model of cutaneous infection with gram-positive cocci.
Infect. Immun.
60:2636-2640[Abstract/Free Full Text].
|
| 9.
|
Carmona, C., and G. L. Gray.
1987.
Nucleotide sequence of the serine protease gene of Staphylococcus aureus, strain V8.
Nucleic Acids Res.
15:6757[Free Full Text].
|
| 10.
|
Chan, P. F., and S. J. Foster.
1998.
Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus.
J. Bacteriol.
180:6232-6241[Abstract/Free Full Text].
|
| 11.
|
Cheung, A. L.,
M. G. Bayer, and J. H. Heinrichs.
1997.
sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus.
J. Bacteriol.
179:3963-3971[Abstract/Free Full Text].
|
| 12.
|
Cheung, A. L.,
K. J. Eberhardt,
E. Chung,
M. R. Yeaman,
P. M. Sullam,
M. Ramos, and A. S. Bayer.
1994.
Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.
J. Clin. Investig.
94:1815-1822.
|
| 13.
|
Cheung, A. L., and S. J. Projan.
1994.
Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr.
J. Bacteriol.
176:4168-4172[Abstract/Free Full Text].
|
| 14.
|
Coulter, S. N.,
W. R. Schwan,
E. Y. Ng,
M. H. Langhorne,
H. D. Ritchie,
S. Westbrock-Wadman,
W. O. Hufnagle,
K. R. Folger,
A. S. Bayer, and C. K. Stover.
1998.
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.
Mol. Microbiol.
30:393-404[CrossRef][Medline].
|
| 15.
|
Drapeau, G. R.
1978.
Role of metalloprotease in activation of the precursor of staphylococcal protease.
J. Bacteriol.
136:607-613[Abstract/Free Full Text].
|
| 16.
|
Drapeau, G. R.,
Y. Boily, and J. Houmard.
1972.
Purification and properties of an extracellular protease of Staphylococcus aureus.
J. Biol. Chem.
247:6720-6726[Abstract/Free Full Text].
|
| 17.
|
Fattom, A. I., and R. Naso.
1996.
Staphylococcal vaccines: a realistic dream.
Ann. Med.
28:43-46[Medline].
|
| 18.
|
Gillaspy, A. F.,
C. Y. Lee,
S. Sau,
A. L. Cheung, and M. S. Smeltzer.
1998.
Factors affecting the collagen binding capacity of Staphylococcus aureus.
Infect. Immun.
66:3170-3178[Abstract/Free Full Text].
|
| 19.
|
Greene, C.,
D. McDevitt,
P. Francois,
P. E. Vaudaux,
D. P. Lew, and T. J. Foster.
1995.
Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes.
Mol. Microbiol.
17:1143-1152[CrossRef][Medline].
|
| 20.
|
Groicher, K. H.,
B. A. Firek,
D. F. Fujimoto, and K. W. Bayles.
2000.
The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance.
J. Bacteriol.
182:1794-1801[Abstract/Free Full Text].
|
| 21.
|
Gubba, S.,
D. E. Low, and J. M. Musser.
1998.
Expression and characterization of group A Streptococcus extracellular cysteine protease recombinant mutant proteins and documentation of seroconversion during human invasive disease episodes.
Infect. Immun.
66:765-770[Abstract/Free Full Text].
|
| 22.
|
Hanahan, D.
1983.
Studies on transformation of Escherichia coli with plasmids.
J. Mol. Biol.
166:557-580[Medline].
|
| 23.
|
Hofmann, B.,
D. Schomburg, and H. J. Hecht.
1993.
Crystal structure of a thiol proteinase from Staphylococcus aureus V-8 in the E-64 inhibitor complex.
Acta Crystallogr.
49(Suppl.):102.
|
| 24.
|
Houmard, J., and G. R. Drapeau.
1972.
Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds.
Proc. Natl. Acad. Sci. USA
69:3506-3509[Abstract/Free Full Text].
|
| 25.
|
Hunter, W. M.
1978.
Radioimmunoassay, p. 14.1-14.40.
In
D. M. Weir (ed.), Handbook of experimental immunology. Blackwell Scientific Publications, Oxford, United Kingdom.
|
| 26.
|
Jolliffe, L. K.,
R. J. Doyle, and U. N. Streips.
1980.
Extracellular proteases modify cell wall turnover in Bacillus subtilis.
J. Bacteriol.
141:1199-1208[Abstract/Free Full Text].
|
| 27.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 28.
|
Lee, C. Y., and J. J. Iandolo.
1986.
Lysogenic conversion of staphylococcal lipase is caused by insertion of the bacteriophage L54a genome into the lipase structural gene.
J. Bacteriol.
166:385-391[Abstract/Free Full Text].
|
| 29.
|
Li, J. K.,
B. Parker, and T. Kowalic.
1987.
Rapid alkaline blot-transfer of viral dsRNAs.
Anal. Biochem.
163:210-218[CrossRef][Medline].
|
| 30.
|
Lowy, F. D.
1998.
Staphylococcus aureus infections.
N. Engl. J. Med.
339:520-532[Free Full Text].
|
| 31.
|
Luchansky, J. B.,
A. K. Benson, and A. G. Atherly.
1989.
Construction, transfer and properties of a novel temperature-sensitive integrable plasmid for genomic analysis of Staphylococcus aureus.
Mol. Microbiol.
3:65-78[CrossRef][Medline].
|
| 32.
|
McGavin, M. J.,
C. Zahradka,
K. Rice, and J. E. Scott.
1997.
Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease.
Infect. Immun.
65:2621-2628[Abstract].
|
| 33.
|
Nakai, K., and M. Kanehisa.
1991.
Expert system for predicting protein localization sites in Gram-negative bacteria.
Proteins
11:95-110[CrossRef][Medline].
|
| 34.
|
Nelson, D.,
J. Potempa,
T. Kordula, and J. Travis.
1999.
Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis. Evidence for a role in the inactivation of human alpha1-proteinase inhibitor.
J. Biol. Chem.
274:12245-12251[Abstract/Free Full Text].
|
| 35.
|
Nikoleit, K.,
R. Rosenstein,
H. M. Verheij, and F. Gotz.
1995.
Comparative biochemical and molecular analysis of the Staphylococcus hyicus, Staphylococcus aureus and a hybrid lipase. Indication for a C-terminal phospholipase domain.
Eur. J. Biochem.
228:732-738[Medline].
|
| 36.
|
Novick, R. P.
1991.
Genetic systems in staphylococci.
Methods Enzymol.
204:587-636[Medline].
|
| 37.
|
Novick, R. P.,
S. J. Projan,
J. Kornblum,
H. F. Ross,
G. Ji,
B. Kreiswirth,
F. Vandenesch, and S. Moghazeh.
1995.
The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus.
Mol. Gen. Genet.
248:446-458[CrossRef][Medline].
|
| 38.
|
Novick, R. P.,
H. F. Ross,
S. J. Projan,
J. Kornblum,
B. Kreiswirth, and S. Moghazeh.
1993.
Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.
EMBO J.
12:3967-3975[Medline].
|
| 39.
|
Oshida, T.,
M. Sugai,
H. Komatsuzawa,
Y. M. Hong,
H. Suginaka, and A. Tomasz.
1995.
A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-alanine amidase domain and an endo-beta-N-acetylglucosaminidase domain: cloning, sequence analysis, and characterization.
Proc. Natl. Acad. Sci. USA
92:285-289[Abstract/Free Full Text].
|
| 40.
|
Papakyriacou, H.,
D. Vaz,
A. Simor,
M. Louie, and M. J. McGavin.
2000.
Molecular analysis of the accessory gene regulator (agr) locus and balance of virulence factor expression in epidemic methicillin-resistant Staphylococcus aureus.
J. Infect. Dis.
181:990-1000[CrossRef][Medline].
|
| 41.
|
Patel, A. H.,
J. Kornblum,
B. Kreiswirth,
R. Novick, and T. J. Foster.
1992.
Regulation of the protein A-encoding gene in Staphylococcus aureus.
Gene
114:25-34[CrossRef][Medline].
|
| 42.
|
Pavloff, N.,
J. Potempa,
R. N. Pike,
V. Prochazka,
M. C. Kiefer,
J. Travis, and P. J. Barr.
1995.
Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein.
J. Biol. Chem.
270:1007-1010[Abstract/Free Full Text].
|
| 43.
|
Potempa, J.,
J. Mikolajczyk-Pawlinska,
D. Brassell,
D. Nelson,
I. B. Thogersen,
J. J. Enghild, and J. Travis.
1998.
Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis.
J. Biol. Chem.
273:21648-21657[Abstract/Free Full Text].
|
| 44.
|
Qin, X.,
K. V. Singh,
G. M. Weinstock, and B. E. Murray.
2000.
Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence.
Infect. Immun.
68:2579-2586[Abstract/Free Full Text].
|
| 45.
|
Qoronfleh, M. W., and B. J. Wilkinson.
1986.
Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of beta-lactams on peptidoglycan structure and susceptibility to lytic enzymes.
Antimicrob. Agents Chemother.
29:250-257[Abstract/Free Full Text].
|
| 46.
|
Rollof, J., and S. Normark.
1992.
In vivo processing of Staphylococcus aureus lipase.
J. Bacteriol.
174:1844-1847[Abstract/Free Full Text].
|
| 47.
|
Sabat, A.,
K. Kosowska,
K. Poulsen,
A. Kasprowicz,
A. Sekowska,
B. van Den Burg,
J. Travis, and J. Potempa.
2000.
Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus.
Infect. Immun.
68:973-976[Abstract/Free Full Text].
|
| 48.
|
Saravia-Otten, P.,
H. P. Muller, and S. Arvidson.
1997.
Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism.
J. Bacteriol.
179:5259-5263[Abstract/Free Full Text].
|
| 49.
|
Shaw, J. H., and D. B. Clewell.
1985.
Complete nucleotide sequence of macrolide-lincosamide-streptogramin B resistance transposon Tn917 in Streptococcus faecalis.
J. Bacteriol.
164:782-796[Abstract/Free Full Text].
|
| 50.
|
Sheagren, J. N.
1988.
Inflammation induced by Staphylococcus aureus, p. 829-840.
In
J. I. Gallen, I. M. Goldstein, and R. Snyderman (ed.), Inflammation: basic principles and clinical correlates. Raven Press, New York, N.Y.
|
| 51.
|
Sheagren, J. N.
1984.
Staphylococcus aureus. The persistent pathogen.
N. Engl. J. Med.
310:1368-1373[Medline].
|
| 52.
|
Short, J. M.,
J. M. Fernandez,
J. A. Sorge, and W. D. Huse.
1988.
Lambda ZAP: a bacteriophage expression vector with in vivo excision properties.
Nucleic Acids Res.
16:7583-7587[Abstract/Free Full Text].
|
| 53.
|
Singh, K. V.,
X. Qin,
G. M. Weinstock, and B. E. Murray.
1998.
Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model.
J. Infect. Dis.
178:1416-1420[CrossRef][Medline].
|
| 54.
|
Sun, Q.,
G. M. Smith,
C. Zahradka, and M. J. McGavin.
1997.
Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding.
Infect. Immun.
65:537-543[Abstract].
|
| 55.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 56.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: Nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103[CrossRef][Medline].
|
| 57.
|
Yuen, S. W.,
A. H. Chui,
K. J. Wilson, and P. M. Yuan.
1989.
Microanalysis of SDS-PAGE electroblotted proteins.
BioTechniques
7:74-82[Medline].
|
Infection and Immunity, January 2001, p. 159-169, Vol. 69, No. 1
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.159-169.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Thomas, V. C., Thurlow, L. R., Boyle, D., Hancock, L. E.
(2008). Regulation of Autolysis-Dependent Extracellular DNA Release by Enterococcus faecalis Extracellular Proteases Influences Biofilm Development. J. Bacteriol.
190: 5690-5698
[Abstract]
[Full Text]
-
Nickerson, N. N., Prasad, L., Jacob, L., Delbaere,